Marc Semigran's most recent trade in Edgewise Therapeutics Inc was a trade of 29,709 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 24, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edgewise Therapeutics Inc | Marc Semigran | Chief Development Officer | 24 Dec 2024 | 29,709 | 270,291 | - | - | Stock Option (Right to Buy) | ||
| Edgewise Therapeutics Inc | Marc Semigran | Chief Development Officer | 24 Dec 2024 | 29,709 | 36,425 | - | 8.9 | 265,598 | Common Stock | |
| Edgewise Therapeutics Inc | Marc Semigran | Chief Development Officer | 24 Dec 2024 | 27,980 | 8,445 | - | 29.7 | 829,906 | Common Stock | |
| Edgewise Therapeutics Inc | Marc Semigran | Chief Development Officer | 24 Dec 2024 | 1,729 | 6,716 | - | 30.1 | 52,009 | Common Stock | |
| Edgewise Therapeutics Inc | Marc Semigran | Chief Development Officer | 12 Aug 2024 | 138,750 | 138,750 | - | - | Stock Option (Right to Buy) | ||
| Edgewise Therapeutics Inc | Marc Semigran | Chief Development Officer | 12 Aug 2024 | 23,125 | 23,125 | - | - | Restricted Stock Units |